As reported that tunicamycin, the drug inhibiting N-linked glycosylation of proteins, prevents the glycosylation of GP73 and attenuates its functions in facilitating HCC metastasis, it is potentially utilized in cancer therapy (34, 114). The gene discussed is GOLM1; the disease is cancer.